Cathepsin K inhibitors for osteoporosis and potential off-target effects.
Cathepsin K inhibitors for osteoporosis and potential off-target effects.
复制标题
DOI:
10.1517/13543780902832661
复制
发表时间:
2009-05
影响因子:
6.1
通讯作者:
Lecaille F
中科院分区:
文献类型:
--
作者:
Brömme D;Lecaille F
Cathepsin K is a highly potent collagenase and the predominant papain-like cysteine protease expressed in osteoclasts. Cathepsin K deficiencies in humans and mice have underlined the central role of this protease in bone resorption and thus rendered the enzyme an attractive target for anti-resorptive osteoporosis therapy. Within the last decade, great efforts have been made in developing highly potent, selective, and orally applicable cathepsin K inhibitors. Some of these inhibitors have passed preclinical studies and are presently in clinical trials at different stages of advancement. The development of the inhibitors and preliminary results of the clinical trials revealed problems and lessons concerning the in situ specificity of the compounds and their tissue targeting. In this review, we will briefly summarize the history of cathepsin K research and will discuss the current development of cathepsin K inhibitors as novel anti-resorptives for the treatment of osteoporosis. We will also discuss potential off-target effects of cathepsin K inhibition and alternative applications of cathepsin K inhibitors in arthritis, atherosclerosis, blood pressure regulation, obesity, and cancer.
登录
查看更多内容
影响因子:
6.2
作者:
Brubaker, KD;Vessella, RL;Corey, E
通讯作者:
Corey, E
影响因子:
5.6
作者:
Chiellini, C;Costa, M;Maffei, M
通讯作者:
Maffei, M
影响因子:
2.7
作者:
Altmann, E;Green, J;Tintelnot-Blomley, M
通讯作者:
Tintelnot-Blomley, M
DOI:
10.1515/bchm3.1995.376.6.379
发表时间:
1995-06-01
期刊:
BIOLOGICAL CHEMISTRY HOPPE-SEYLER
影响因子:
--
作者:
BROMME, D;OKAMOTO, K
通讯作者:
OKAMOTO, K
影响因子:
2.7
作者:
Barrett, DG;Boncek, VM;Zhou, HQQ
通讯作者:
Zhou, HQQ